#digipath pathologist | Explore Tumblr Posts and Blogs

pathologyucgconference · 2 years

Text

Digital Pathology's Function And How Can It Help With Healthcare? To Learn More, Join us at the 10DIGIPATH202

Digital pathology exemplifies innovation and a dedication to excellence in healthcare, with a focus on supporting pathology training, clinical research, informatics, and the global practice of human pathology.

Through the digitalization of conventional analogue procedures, technology has significantly altered the pathology landscape. The following criteria can all be improved by the use of digital pathology, including patient safety, pathology workflow, service quality, and workforce factors:

accuracy of diagnosis Digital pathology minimises classification and diagnostic pathology errors and creates techniques for individualised medical care:

For the pathologist, high definition digital slides offer higher image clarity and more detail.

The ability for comparisons with digital slides from prior cases and a variety of viewing choices allow for far more precise and rapid findings for patients.

speedier and more effective procedures. Digital pathology reduces monotonous, repetitive, and mind-numbing work:

It enables doctors to concentrate on providing effective medical care for disorders that have been correctly diagnosed.

It enhances workflow, increasing productivity and scalability in the laboratory setting. With a dashboard view of data and annotations, pathologists can quickly review previous cases. This shortens the time it takes to retrieve, match, and organise data.

The benefits of digital pathology

There are several benefits associated with using digital pathology, and these benefits are assisting in the practice's widespread adoption and widespread application in lab settings.

enhanced analysis

To start, digital pathology provides better analysis. It offers automatic slide analysis methods that are unbiased, quick, and precise. Additionally, it gives researchers immediate access to earlier comparable cases, serving as data storage for long-term predictive analytics.

decrease in errors

Additionally, because digital photos are saved, breakages do not pose a threat to data due to the use of digital pathology, which reduces mistakes like misidentification.

improving imaging

Additionally, the procedure allows scientists to magnify the slides and see them from various perspectives, providing greater views of the materials. Additionally, it enables the annotation and measurement of numerous places of interest.

better results for patients

One of the key responsibilities of pathologists is to provide a diagnosis for a patient using tissue samples, leaving a crucial choice to one person or a small number of people. Even if the person assessing the samples is an expert, they are still susceptible to human error when diagnosing in this fashion.

Digital pathology can produce accurate diagnosis results quickly while also minimizing human error. Digital pathology's techniques enable it to expedite typical tasks without compromising the effectiveness of each task's execution.

Thank You For Visit My Blog.

Mail: [email protected]| [email protected]

WhatsApp: +442033222718

Call: +12073070027

Reference Digital Pathology UCGConferences press releases and blogs

0 notes

marketstudyreport · 5 years

Text

Digital Pathology Market Size, Share and Competitive Landscape 2014-2025

20th March 2020 - The global Digital Pathology Market is predicted to witness substantial growth in the coming years due to increasing need to improve the existing diagnostics imaging measures and reduce the cost of traditional diagnostics. Digital pathology is a powerful image-based environment for data acquisition and interpretation of examined data obtained from the slide. It is majorly used in healthcare applications and life sciences.

Currently, digital pathology is indispensable to gain a wide popularity since it greatly assists the healthcare professionals in diagnosis and treatment, specifically supports the education domain, used widely in research and development of large number of drugs, and also it is an important tool for human laboratory practice on the global scale. It delivers improved analysis that helps physicians and experts in decision making, speedy access to emergency cases, and data storage for future predictive analysis, offers live zooming option with multiple angle views, enable team annotation for slides, and reduce errors or misidentification.

The key drivers of the digital pathology market include increasing awareness of digital pathology across the globe and growing adoption, rising technological enhancement in the analysis software, increasing prevalence of cancer, high efficiency of pathological assessment, increased workload of pathologists, and delivery of superior results. However, strict regulations and significant cost of the systems are few restraining factors in the digital pathology industry.

Access Digital Pathology Market Report with TOC @ https://www.millioninsights.com/industry-reports/digital-pathology-market

Increasing focus on improving the efficiency of workflow and adoption of quicker diagnostic tools for chronic disorders is trending in the digital pathology market. Nonetheless, digital pathology has several advantages over the traditional techniques, which is expected to offer lucrative opportunity for various applications.

With an aim of improving digital pathology services, Neuberg Diagnostics, a prominent player in the industry merged with OptraSCAN Inc. US, for the introduction of ‘Neuberg DIGIPATH by OptraSCAN Inc’. With a highly proficient team based in UAE, India, and South Africa, this venture offers solution for digitized tissue slides and tele-pathology demanded by medical institutes, hospitals, and the physicians.

Moreover, since the digital pathology domain is gaining momentum in India, the associated instruments are significantly priced, making it difficult for the customers to purchase. But the services offered by this merger are predicted to support pathologists and private hospitals in terms of better-quality scanner, telepathology software platform, image management tools, along with Neuberg’s histopathology network.

The leading players are OLYMPUS CORPORATION, Sectra AB, F. Hoffmann-La Roche Ltd, Mikroscan Technologies, Inc., Leica Biosystems Imaging Inc., GE Healthcare, Inspirata, and Koninklijke Philips N.V.

Request a Sample Copy of Digital Pathology Market Report @

https://www.millioninsights.com/industry-reports/digital-pathology-market/request-sample

1 note · View note

marketanalysisdata · 5 years

Text

Digital Pathology Market Growth Analysis, Trends Forecast by Regions and Types to 2025

Access Digital Pathology Market Report with TOC @ https://www.millioninsights.com/industry-reports/digital-pathology-market

The leading players are OLYMPUS CORPORATION, Sectra AB, F. Hoffmann-La Roche Ltd, Mikroscan Technologies, Inc., Leica Biosystems Imaging Inc., GE Healthcare, Inspirata, and Koninklijke Philips N.V.

Request a Sample Copy of Digital Pathology Market Report @

https://www.millioninsights.com/industry-reports/digital-pathology-market/request-sample

1 note · View note

chitrakullkarni · 3 years

Text

Digital Pathology Market Rapid Technological Advancements, Revenue Drivers & Restraints Analysis

The global Digital Pathology Market is predicted to witness substantial growth in the coming years due to the increasing need to improve the existing diagnostics imaging measures and reduce the cost of traditional diagnostics. Digital pathology is a powerful image-based environment for data acquisition and interpretation of examined data obtained from the slide. It is majorly used in healthcare applications and life sciences.

Currently, digital pathology is indispensable to gain wide popularity since it greatly assists the healthcare professionals in diagnosis and treatment, specifically supports the education domain, used widely in research and development of a large number of drugs, and also it is an important tool for human laboratory practice on the global scale. It delivers improved analysis that helps physicians and experts in decision making, speedy access to emergency cases, and data storage for future predictive analysis, offers a live zooming option with multiple angle views, enables team annotation for slides, and reduces errors or misidentification.

The key drivers of the digital pathology market include increasing awareness of digital pathology across the globe and growing adoption, rising technological enhancement in the analysis software, increasing prevalence of cancer, high efficiency of pathological assessment, increased workload of pathologists, and delivery of superior results. However, strict regulations and significant costs of the systems are a few restraining factors in the digital pathology industry.

Request free sample to get a complete analysis @ https://www.millioninsights.com/industry-reports/digital-pathology-market/request-sample

Increasing focus on improving the efficiency of workflow and adoption of quicker diagnostic tools for chronic disorders is trending in the digital pathology market. Nonetheless, digital pathology has several advantages over traditional techniques, which are expected to offer lucrative opportunities for various applications.

With an aim of improving digital pathology services, Neuberg Diagnostics, a prominent player in the industry merged with OptraSCAN Inc. US, for the introduction of ‘Neuberg DIGIPATH by OptraSCAN Inc’. With a highly proficient team based in UAE, India, and South Africa, this venture offers solutions for digitized tissue slides and telepathology demanded by medical institutes, hospitals, and physicians.

Moreover, since the digital pathology domain is gaining momentum in India, the associated instruments are significantly priced, making it difficult for the customers to purchase. But the services offered by this merger are predicted to support pathologists and private hospitals in terms of better-quality scanners, telepathology software platform, image management tools, along with Neuberg’s histopathology network.

The leading players are OLYMPUS CORPORATION, Sectra AB, F. Hoffmann-La Roche Ltd, Mikroscan Technologies, Inc., Leica Biosystems Imaging Inc., GE Healthcare, Inspirata, and Koninklijke Philips N.V.

Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/

0 notes

daisyri-me · 3 years

Text

Digital Pathology Market Determined by Business Summary, Industry Profile, Products, Services and Solutions Forecast 2025

The global Digital Pathology Market is predicted to witness substantial growth in the coming years due to increasing need to improve the existing diagnostics imaging measures and reduce the cost of traditional diagnostics. Digital pathology is a powerful image-based environment for data acquisition and interpretation of examined data obtained from the slide. It is majorly used in healthcare applications and life sciences.

Access Sample Report of this report @ https://www.millioninsights.com/industry-reports/digital-pathology-market/request-sample

The leading players are OLYMPUS CORPORATION, Sectra AB, F. Hoffmann-La Roche Ltd, Mikroscan Technologies, Inc., Leica Biosystems Imaging Inc., GE Healthcare, Inspirata, and Koninklijke Philips N.V.

Browse Full Report With TOC @ https://www.millioninsights.com/industry-reports/digital-pathology-market

Market Segment:

Digital Pathology Technology Outlook (Revenue, USD Million; Volume, 000 Units, 2014 - 2025) • Whole Slide Imaging • Telepathology • Static • Dynamic

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:[email protected]

#Digital Pathology Market

0 notes

market-researchm · 4 years

Text

Digital Pathology Market Share, Sales Price, Specification Forecast to 2025

The Digital Pathology Market report discusses the primary market growth drivers and challenges that the vendors and the market as a whole face and provides an overview of the key trends emerging in the market. It also talks about the market size of different segments and their growth aspects along with key leading countries in Americas, Asia-Pacific, Europe, the Middle East, and Africa regions.

Download Free Sample Report Now @ https://www.millioninsights.com/industry-reports/digital-pathology-market/request-sample

Some of the major objectives of this report:

1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Digital Pathology Market.

2. To provide insights about factors affecting the market growth. To analyze the Digital Pathology Market based on various factors- price analysis, supply chain analysis, porter five force analysis etc.

3. To provide historical and forecast revenue of the Digital Pathology Market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.

4. Country level analysis of the market with respect to the current market size and future prospective.

5. To provide country level analysis of the market for segment by application, product type and sub-segments.

6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.

7. Track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Digital Pathology Market.

The leading players are OLYMPUS CORPORATION, Sectra AB, F. Hoffmann-La Roche Ltd, Mikroscan Technologies, Inc., Leica Biosystems Imaging Inc., GE Healthcare, Inspirata, and Koninklijke Philips N.V.

Know More Insights @ https://latestmarketstudy.wordpress.com

#Digital Pathology Market

0 notes

epucg2020dubai · 4 years

Photo

We invite Pathologists, healthcare experts to submit their abstracts for the #EPUCG2020 conference from Dec 1-3, 2020 Submit here: https://pathology.universeconferences.com/submit-abstract/ #pathology #pathologists #surgicalpathology #microscope #physician #pathologyresident #surgpath #cytology #pathart #dermpath #labmed #HemePath #pathinformatics #microbiology #ClinPath #Cytopath #ENTpath #EndoPath #digipath

#pathology pathologists surgicalpathology microscope physician pathologyresident surgpath cytology pathart dermpath labmed HemePath pathinfor

0 notes

kdmarketresearch · 5 years

Text

Digital Pathology Market Value Set to Grow at CAGR of 14.8% during the forecast Year 2017-2023

A New fresh research report presented by KD Market research provides a detailed analysis of “Digital Pathology Market“ research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business is going through. The research provides a complete understanding of the “Digital Pathology Market“ in terms of revenue.

Request sample copy@ https://www.kdmarketresearch.com/sample/3344

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled by computer technology that allows the management of information generated through a digital slide. Digitalization of pathology has led to the automation of tests during disease diagnosis among other applications. For instance, a single digital instrument can perform tests that were previously carried out using five instruments by pathologists. Digital pathology solutions offer scrutiny & analysis of images on a computer, high-resolution sample scanning, and online storage of digital slides, which enable pathologists to cross examine slides without physical evidences.

Efficient cost of digital pathology products, ease of virtual transportation of slides, and high efficiency of digital pathology systems are the major factors that boost the growth of the global digital pathology market. In addition, higher adoption of digital pathology as compared to conventional pathology diagnosis drives the market growth. On the other hand, barriers such as unclear reimbursement policies, dearth of skilled personnel, and unwillingness of older pathologists to adopt to new technology restrain the market growth. However, rise in initiatives towards commercialization of cost-efficient digital pathology systems is anticipated to offer profitable growth opportunities for service providers in the future.

The global digital pathology market is segmented on the basis of product, type, end user, and region. Based on product, the market is categorized into whole slide imaging, image analysis informatics, information management system storage & communication, digital IVD devices, and others (telepathology). By type, it is classified into automated hematology analyzers & blood cell counters, chromosome analyzers, FISH enumeration systems, urine sediment analyzers, immunohistochemistry image analysis applications, digital cytopathology, digital PCR, signet cell detection, and digital holographic microscopy. Depending on end user, it is fragmented into educational, clinical, pharma & biotech companies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

-The study provides an in-depth analysis of the global digital pathology market, with current trends and future estimations to elucidate the imminent investment pockets.

-Comprehensive analysis of factors that drive and restrict the market growth is provided.

-Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.

-Extensive analysis of the key segments of the industry helps understand the type of digital pathology used globally.

-Key market players and their strategies are provided to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

-Whole Slide Imaging -Image Analysis Informatics -Information Management System Storage & Communication -Digital IVD Devices -Others (Telepathology)

By Type

-Automated Hematology Analyzers & Blood Cell Counters -Chromosome Analyzers -Fish Enumeration Systems -Urine Sediment Analyzers -Immunohistochemistry Image Analysis Applications -Digital Cytopathology -Digital PCR -Signet Cell Detection -Digital Holographic Microscopy

By End User

-Educational -Clinical -Pharma & Biotech Companies

By Region

-North America -U.S. -Canada -Mexico -Europe -Germany -France -UK -Italy -Spain -Russia -Rest of Europe -Asia-Pacific -Japan -China -Australia -India -South Korea -Taiwan -Rest of Asia-Pacific -LAMEA -Brazil -Turkey -Venezuela -Saudi Arabia -Rest of LAMEA

KEY PLAYERS PROFILED

-Danaher Corporation -Digipath Inc. -Glencoe Software, Inc. -Hamamatsu Photonics K.K. -Indica Labs, Inc. -Koninklijke Philips N.V. -Nikon Corporation -PerkinElmer, Inc. -Pixcelldata Ltd. -Visiopharm A/S

The other players in the value chain include (profiles not included in the report)

-Leica Biosystems -Ventana Medical Systems -3DHISTECH -HCL Technologies -Pathology Devices, Inc. -Biogeniux -OptraSCAN -Pathcore -Sectra

Have any Enquiry about this Report@ https://www.kdmarketresearch.com/report/3344/digital-pathology-market-amr

Table of Content

CHAPTER 1: INTRODUCTION

1.1. Report description 1.2. Key benefits for stakeholders 1.3. Key market segments 1.4. Research methodology

1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope 3.2. Key findings

3.2.1. Top investment pockets

3.3. Porters five forces analysis 3.4. Top player positioning 3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Use of digital pathology in disease diagnosis 3.5.1.2. Growing trend of digitalization in medical sector 3.5.1.3. Ease of consultation 3.5.1.4. Diagnosis in remote regions

3.5.2. Restraints

3.5.2.1. Lack in reimbursement 3.5.2.2. High cost of digital pathology solutions

3.5.3. Opportunity

3.5.3.1. Increasing potential of digital pathology

CHAPTER 4: DIGITAL PATHOLOGY MARKET BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Whole Slide Imaging

4.2.1. Key trends and opportunities 4.2.2. Market size and forecast 4.2.3. Market analysis, by country

4.3. Image Analysis-Informatics

4.3.1. Key trends and opportunities 4.3.2. Market size and forecast 4.3.3. Market analysis, by country

4.4. Information Management System Storage & Communication

4.4.1. Key trends and opportunities 4.4.2. Market size and forecast 4.4.3. Market analysis, by country

4.5. Digital IVD Devices

4.5.1. Key trends and opportunities 4.5.2. Market size and forecast 4.5.3. Market analysis, by country

4.6. Other (Telepathology)

4.6.1. Key trends and opportunities 4.6.2. Market size and forecast 4.6.3. Market analysis, by country

CHAPTER 5: DIGITAL PATHOLOGY MARKET BY TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Automated Hematology Analyzers And Blood Cell Counters

5.2.1. Market size and forecast 5.2.2. Market analysis, by country

5.3. Chromosome Analyzers

5.3.1. Market size and forecast 5.3.2. Market analysis, by country

5.4. FISH Enumeration Systems

5.4.1. Market size and forecast 5.4.2. Market analysis, by country

5.5. Urine Sediment Analyzers

5.5.1. Market size and forecast 5.5.2. Market analysis, by country

5.6. Immunohistochemistry Image Analysis Applications

5.6.1. Market size and forecast 5.6.2. Market analysis, by country

5.7. Digital Cytopathology

5.7.1. Market size and forecast 5.7.2. Market analysis, by country

5.8. Digital PCR

5.8.1. Market size and forecast 5.8.2. Market analysis, by country

5.9. Signet Cell Detection

5.9.1. Market size and forecast 5.9.2. Market analysis, by country

5.10. Digital Holographic Microscopy

5.10.1. Market size and forecast 5.10.2. Market analysis, by country

CHAPTER 6: DIGITAL PATHOLOGY MARKET BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Educational

6.2.1. Market size and forecast 6.2.2. Market analysis, by country

6.3. Clinical

6.3.1. Market size and forecast 6.3.2. Market analysis, by country

6.4. Pharma & Biotech Companies

6.4.1. Market size and forecast 6.4.2. Market analysis, by country

CHAPTER 7: DIGITAL PATHOLOGY MARKET BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities 7.2.2. North America market size & forecast for digital pathology market by country 7.2.3. North America market size & forecast for digital pathology market by product 7.2.4. North America market size & forecast for digital pathology market by type 7.2.5. North America market size & forecast for digital pathology market by end user

7.2.5.1. U.S. market size & forecast for digital pathology market by product 7.2.5.2. U.S. market size & forecast for digital pathology market by type 7.2.5.3. U.S. market size & forecast for digital pathology market by end user 7.2.5.4. Canada market size & forecast for digital pathology market by product 7.2.5.5. Canada market size & forecast for digital pathology market by type 7.2.5.6. Canada market size & forecast for digital pathology market by end user 7.2.5.7. Mexico market size & forecast for digital pathology market by product 7.2.5.8. Mexico market size & forecast for digital pathology market by type 7.2.5.9. Mexico market size & forecast for digital pathology market by end user

7.3. Europe

7.3.1. Key trends and opportunities 7.3.2. Europe market size & forecast for digital pathology market by country 7.3.3. Europe market size & forecast for digital pathology market by product 7.3.4. Europe market size & forecast for digital pathology market by type 7.3.5. Europe market size & forecast for digital pathology market by end user

7.3.5.1. Germany market size & forecast for digital pathology market by product 7.3.5.2. Germany market size & forecast for digital pathology market by type 7.3.5.3. Germany market size & forecast for digital pathology market by end user 7.3.5.4. France market size & forecast for digital pathology market by product 7.3.5.5. France market size & forecast for digital pathology market by type 7.3.5.6. France market size & forecast for digital pathology market by end user 7.3.5.7. UK market size & forecast for digital pathology market by product 7.3.5.8. UK market size & forecast for digital pathology market by type 7.3.5.9. UK market size & forecast for digital pathology market by end user 7.3.5.10. Italy market size & forecast for digital pathology market by product 7.3.5.11. Italy market size & forecast for digital pathology market by type 7.3.5.12. Italy market size & forecast for digital pathology market by end user 7.3.5.13. Spain market size & forecast for digital pathology market by product 7.3.5.14. Spain market size & forecast for digital pathology market by type 7.3.5.15. Spain market size & forecast for digital pathology market by end user 7.3.5.16. Russia market size & forecast for digital pathology market by product 7.3.5.17. Russia market size & forecast for digital pathology market by type 7.3.5.18. Russia market size & forecast for digital pathology market by end user 7.3.5.19. Rest of Europe market size & forecast for digital pathology market by product 7.3.5.20. Rest of Europe market size & forecast for digital pathology market by type 7.3.5.21. Rest of Europe market size & forecast for digital pathology market by end user

7.4. Asia-Pacific

7.4.1. Key trends and opportunities 7.4.2. Asia-Pacific market size & forecast for digital pathology market by country 7.4.3. Asia-Pacific market size & forecast for digital pathology market by product 7.4.4. Asia-Pacific market size & forecast for digital pathology market by type 7.4.5. Asia-Pacific market size & forecast for digital pathology market by end user

7.4.5.1. Japan market size & forecast for digital pathology market by product 7.4.5.2. Japan market size & forecast for digital pathology market by type 7.4.5.3. Japan market size & forecast for digital pathology market by end user 7.4.5.4. China market size & forecast for digital pathology market by product 7.4.5.5. China market size & forecast for digital pathology market by type 7.4.5.6. China market size & forecast for digital pathology market by end user 7.4.5.7. Australia market size & forecast for digital pathology market by product 7.4.5.8. Australia market size & forecast for digital pathology market by type 7.4.5.9. Australia market size & forecast for digital pathology market by end user 7.4.5.10. India market size & forecast for digital pathology market by product 7.4.5.11. India market size & forecast for digital pathology market by type 7.4.5.12. India market size & forecast for digital pathology market by end user 7.4.5.13. South Korea market size & forecast for digital pathology market by product 7.4.5.14. South Korea market size & forecast for digital pathology market by type 7.4.5.15. South Korea market size & forecast for digital pathology market by end user 7.4.5.16. Taiwan market size & forecast for digital pathology market by product 7.4.5.17. Taiwan market size & forecast for digital pathology market by type 7.4.5.18. Taiwan market size & forecast for digital pathology market by end user 7.4.5.19. Rest of Asia-Pacific market size & forecast for digital pathology market by product 7.4.5.20. Rest of Asia-Pacific market size & forecast for digital pathology market by type 7.4.5.21. Rest of Asia-Pacific market size & forecast for digital pathology market by end user

7.5. LAMEA

7.5.1. Key trends and opportunities 7.5.2. LAMEA market size & forecast for digital pathology market by country 7.5.3. LAMEA market size & forecast for digital pathology market by product 7.5.4. LAMEA market size & forecast for digital pathology market by type 7.5.5. LAMEA market size & forecast for digital pathology market by end user

7.5.5.1. Brazil market size & forecast for digital pathology market by product 7.5.5.2. Brazil market size & forecast for digital pathology market by type 7.5.5.3. Brazil market size & forecast for digital pathology market by end user 7.5.5.4. Turkey market size & forecast for digital pathology market by product 7.5.5.5. Turkey market size & forecast for digital pathology market by type 7.5.5.6. Turkey market size & forecast for digital pathology market by end user 7.5.5.7. Venezuela market size & forecast for digital pathology market by product 7.5.5.8. Venezuela market size & forecast for digital pathology market by type 7.5.5.9. Venezuela market size & forecast for digital pathology market by end user 7.5.5.10. Saudi Arabia market size & forecast for digital pathology market by product 7.5.5.11. Saudi Arabia market size & forecast for digital pathology market by type 7.5.5.12. Saudi Arabia market size & forecast for digital pathology market by end user 7.5.5.13. Rest of LAMEA market size & forecast for digital pathology market by product 7.5.5.14. Rest of LAMEA market size & forecast for digital pathology market by type 7.5.5.15. Rest of LAMEA market size & forecast for digital pathology market by end user

Request Exclusive Discount on this Report @ https://www.kdmarketresearch.com/discount/3344

About Us:

KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.

Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.

KD Market Research

150 State Street, Albany,

New York, USA 12207

Website: www.kdmarketresearch.com

Email id- [email protected]

More - https://kdmarketresearch.blogspot.com/

#Digital Pathology Market size #Digital Pathology Market news #Digital Pathology Market trends #Digital Pathology Market Forecast #Digital Pathology Market Analysis

0 notes

fmihealthcare-blog · 6 years

Text

Digital Pathology Market will expand at a healthy CAGR of 11.4% during the forecast period North America Region 2015-2025

Digital pathology enables pathologists to analyze, evaluate and share pathology outcomes remotely. The introduction of digital pathology in healthcare and life science applications has significantly reduced laboratory expenses and improved operational efficiency and productivity. The integration of conventional pathology operations with digital pathology in healthcare applications has enhanced treatment decision and patient care. According to the latest research by Future Market Insights (FMI), the global digital pathology market was valued at US$ 326.7 Mn in terms of value in 2015. The report on digital pathology further projects significant growth potential with an average year-on-year growth rate of 11.4% through 2025.

Digital Pathology Market: Overview & Analysis

The global digital pathology industry is largely dominated by the histopathology application segment, which is part of the tissue diagnostics market. The digital pathology market has witnessed a significant transformation in terms of adoption across developed countries of Europe and North America over the recent past. Companies are not focused on the commercialization of cheaper digital pathology solutions in the APAC market as they already have a large consumer base in the region. Continuous efforts from AI service providers to integrate digital pathology solutions with commercial diagnostics are expected to hold key growth opportunities in the market. The recent collaboration between Microsoft India and SRL Diagnostics will empower the pathology services of SRL Diagnostics with Microsoft’s Azure and AI innovations. This collaboration will enable Microsoft to use a repository of more than a million histopathology slides of SRL Diagnostics for training an AI algorithm. The increasing prevalence of chronic diseases such as cancer is demanding more reliable and cost-effective diagnostic platforms for pathology laboratories.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-124

Digital pathology imaging solutions have transformed the day-to-day operations image analysis and interpretation of histopathology images in pathology laboratories. The cost effectiveness and remote pathology review of digital pathology are attracting health and pharmaceutical sectors as well as education and contract research organizations. According to Pharmaceutical Research and Manufacturers of America (PhRMA), the overall spending on drug discovery and development was around US$ 90.0 Bn in 2016. Digital pathology has witnessed significant application in drug discovery and development, especially in preclinical GLP pathology and oncology clinical trials. Digital pathology technology is transforming the mode of drug delivery by enabling data sharing and integrating dispersed pharmaceutical pathology laboratories worldwide. Digital pathology technologies are primarily used for research purposes and are increasingly gaining prominence as one of the most competent technologies for pathology. The growing use of digital pathology technologies in drug discovery is a major factor expected to drive the growth of the global digital pathology market.

The introduction of novel digital pathology tools in clinical diagnostics is expected to create major potential opportunities for investors over the forecast period. This can be attributed to the vast potential of digital pathology platforms in histopathology screening. Such promising opportunities for digital pathology in histopathology screening are also expected to present the histopathology screening service segment as an increasingly lucrative option for investment. The application of digital pathology in medical microbiology and hematology is likely to gain momentum by late 2020 due to the strong barriers with regard to the adoption of digital pathology technologies. These barriers include the high capital costs of products, lack of regulatory standards for commercial application and lack of product awareness among end users.

FMI has segmented the global digital pathology market on the basis of product type, end user, pathology screening service and region. In terms of revenue, the instrument segment is expected to hold a substantial market share over the forecast period. The segment is expected to exhibit a healthy CAGR of 12.0% over the forecast period.

Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-124

FMI’s report covers some of the key companies operating in the digital pathology market, which include Perkin Elmer, Inc., Sectra AB, Definiens AG, 3D-Histech Ltd., Ventana Medical Systems, Koninklijke Philips N.V, GE Healthcare, Olympus Corporation, Inspirata Inc., Leica Biosystems, Digipath Co., Zeiss, Yokogawa Electronic Corporation Hamamatsu Photonics, K.K. and Quorum Technologies Inc.

0 notes

dpathucgconforences · 2 years

Text

Automation in Pathology Will be enabled by Artificial Intelligence

Artificial intelligence is a topic that is now being discussed widely. AI, or artificial intelligence, is the capability of computing systems to be programmed to accomplish tasks AND to learn from those tasks to improve their abilities the next time the system is faced with a problem, question, or decision.

10th World Digital Pathology & AI 10th 2023

We’ve all heard about self-driving cars, voice recognition technology, face recognition technology, and of course the application of AI to the field of pathology in medicine. Many people in our industry have taken on the challenge of programming computers to create algorithms that can review human pathology slides, find rare events (isolated micro metastases), spots of dedifferentiation or stromal changes inside a tumour that may predict biologic behaviour, or help automate repetitive and/or laborious tasks in slide reviews.

Reserve your seat here: https://digitalpathology.ucgconferences.com/

Of course, the worry that pathologists will be replaced by machines has come up at every conference and bar discussion on the subject. We in the community of digital pathology, however, have a different perspective. We see AI as a tool that will help us perform what we already do more effectively, more quickly, and more affordably. Over time, accuracy may also increase.

If you haven’t checked in on your phone before, a kiosk will check you in when you arrive at the airport and, if necessary, print your ticket with your assigned seat. That is, of course, if you didn’t already have it on your phone before leaving for the airport. At security at the gate, you scan your ticket or phone before boarding the aircraft.

Join our upcoming 10th World Digital Pathology & AI conference

Milking dairy cows twice a day is required. Everyday. If you’re a dairy farmer, no vacations. Years ago, gathering the milk, storing it, getting it into a container to be picked up by a truck, and then taking it to be pasteurised, bottled, and distributed to supermarkets were all manual processes.

More milk is produced with improved efficiency and safety thanks to RFID technology and automation in the milking, storage, shipping, pasteurising, and bottling processes today. Your refrigerator’s gallon of milk is delivered twice as quickly and for half the price.

Don’t miss this opportunity to join the 10th World Digital Pathology & AI Conference and get CME/CPD certification.

How pathologists will use all the extra time to generate the same or more money with support from automation is, in my opinion, one of the many questions regarding AI in pathology that will need to be answered. Consider the possibility that AI might increase our productivity by 20–30%. Does that imply a weekly day off from work? additional time to complete papers? or instruct? Or perhaps you should return to the Wednesdays you used to play golf and meet with your accountant?

Or pathology will become even more commoditized through automation and price constraints. Will volume-based remuneration continue to be paid rather than being boosted to account for the additional CPTs and RVUs. When calculating reimbursement, will Medicare and commercial insurers decide that a computer is less expensive than a doctor?

Or will automation allow those of us taking the place of the ageing pathologists to make up for the rise in our workload, the ageing pathologist population, the decline in the number of medical students entering the field, and the lack of new residencies in the near future? We can generate twice as much with AI, which will help us meet the increased demand for our services.

This creates the ideal time for AI in pathology since it is not a question of whether we want to utilise it or not; rather, we must embrace it.

Important Information:

Conference Name: 10th World Digital Pathology & AI UCGCongress Dates April 04–06, 2023 Venue: Berlin, Germany Audience: Global Leaders, Industrialists, Business Delegates, Students, Entrepreneurs, Executives. Email: [email protected] Visit: https://digitalpathology.ucgconferences.com/ Call for Papers: https://digitalpathology.ucgconferences.com/submit-abstract/ Register here: https://digitalpathology.ucgconferences.com/registration/ Call Us: +12073070027WhatsApp Us: +4420332227110

Reference Digital Pathology & AI UCG conferences blogs:

#digipath pathologist #surgicalpathology #covid #digitalpathology

0 notes

pathologyucgconference · 2 years

Text

Deep Learning Strengthens Digital Pathology's Ability to Diagnose Cancer

Imaging classification, which involves categorising histopathology pictures, is prototypically and successfully accomplished by deep learning.

Deep learning is used by several research teams to make medical diagnoses, particularly for cancer disorders. particularly in the digitization of histopathology slides and the use of deep learning-based methods to mine the subvisual morphometric phenotypes for better pathology diagnosis.

In this perspective article, we give an overview of the main deep learning algorithms used in digital pathology and talk about the opportunities and limitations these approaches present for digital pathology's use in cancer diagnosis. Specifically, the newly developed graph neural network may enhance the effectiveness and interpretability of deep

Digital pathology commonly referred to as "whole-slide imaging," is the technique of scanning regular glass slides and digitally stitching together a series of photos to create a single, complete image that matches the data on the glass slide. In order to provide pathologists with a comprehensive picture of the patient's specific cancer, this virtual image is coupled with relevant clinical data. Then, pathologists can conduct additional diagnostic procedures, such as image analysis studies that cannot be done on conventional glass slides.

For more info join us: at the 10th World Digital Pathology & AI UCGCongress on April 04-06, 2023 in Berlin, Germany

A pathologist's trained eye and anticipatory computer algorithms can be used to see, modify, and analyze these enhanced images on a computer as opposed to those on glass slides.

The use of pathology to detect cancer has been considerably altered by digital pathology, which has also opened up new research possibilities.

Using tumor cells mounted on glass slides and examined under a microscope, traditional pathology services are carried out. Although the diagnosis is based on the reviewing pathologist's knowledge and experience, it is subjective. If a second opinion is required, sharing pathologic photos is likewise a challenging and time-consuming process.

What are the deep learning methods for cancer diagnosis?

Deep Learning Strategies

• Boltzmann Machines

• Transfer Learning

• Generative Adversarial Networks

• Autoencoders

• Classic Neural Networks

• Convolutional Neural Networks

• Recurrent Neural Networks (RNNs)

A computed tomography (CT) scan, bone scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, ultrasound, and Xray are a few of the imaging procedures that can be used to diagnose cancer. Biopsy. Your physician takes a sample of cells during a biopsy to be examined in a lab.

A pathologist's description of all the results of their microscopic and visual examination of the tissue specimen, along with pertinent clinical data, can be found in the diagnostic portion of a pathology report. The type of cancer, together with the tumour grade, lymph node status, margin status, and stage, will be mentioned in this section.

Thank You For Visit My Blog.

Mail: [email protected] | [email protected]

WhatsApp: +442033222718

Call: +12073070027

Reference Digital Pathology UCGConferences press releases and blogs

0 notes

latestmarketresearchnews · 5 years

Text

Digital Pathology Market Geographic Segmentation, Analysis by Types and Regions and Forecast to 2025

Access Digital Pathology Market Report with TOC @ https://www.millioninsights.com/industry-reports/digital-pathology-market

The leading players are OLYMPUS CORPORATION, Sectra AB, F. Hoffmann-La Roche Ltd, Mikroscan Technologies, Inc., Leica Biosystems Imaging Inc., GE Healthcare, Inspirata, and Koninklijke Philips N.V.

Request a Sample Copy of Digital Pathology Market Report @ https://www.millioninsights.com/industry-reports/digital-pathology-market/request-sample

0 notes

saojip13 · 5 years

Text

Digital Pathology Market Major Players: Perkin Elmer, Inc., Olympus Corporation, AstraZeneca plc, Sectra AB, etc

Digital pathology can be defined as image-based information for the analysis, management, and interpretation of information achieved from a digital slide. In the field of pathology digital pathology is emerging technology. In the modern technology, specimen samples containing slides are converted into digital images for easy view, storage, analysis, and management of data collected and this enables the virtual microscopy, technology that enables posting image and transmission throughout the network connected. Data rich image helps in maintenance of patient health records electronically, therefore helps to compile and distribute the information to build the central database.

Get a Sample Copy of this Report @ https://www.alexareports.com/report-sample/170623

The growth of digital pathology globally anticipated grow at significant rate owing to the cost-effective procedures, ease of slides transportation virtually, and high efficient analysis of digital slides. Images can processed by computing algorithms, and can produce enhanced output. Furthermore, the time required for the diagnosis also reduced significantly through digital pathology techniques. In addition, low chances of errors in observation as well as interpretation make it the digital pathology as most significant technology in the pathology. Therefore, digital pathology showing increased adaptation rates over the conventional pathology treatments. Based on aforementioned factors digital pathology market is expected to show significant growth rate over the forecast period. However, lack of skilled personnel and unfavourable reimbursement policies are factors that expected to hamper the market growth.

Digital Pathology Market segmented based on product, type, application, end user, and region.

Based on product, digital pathology market segmented as:

Scanners Software Communication Systems Storage Systems

Based on type, digital pathology market is segmented as:

Human Digital Pathology Animal Digital Pathology

Based on application, digital pathology market is segmented as:

Tele consultation Disease Diagnosis Drug Discovery

Based on the end user, digital pathology market is segmented as:

Hospitals Pharmaceutical companies Academic institutes

Grab amazing discount here @ https://www.alexareports.com/check-discount/170623

Digitalization of pathology led to the automation of the tests during diagnosis, thus saving cost and efforts. For example, now a single digital instrument can perform those tests that were previously performed using five instruments by pathologists. The net effect has been observed in the form of impressive cost-reduction in total cost of diagnostic procedures and services. Digitization of tissue slides offers pathologists ease in diagnosis and detection of disease and digitized tissue can be analyzed using computer algorithms. The advancements in digital pathology is expected to take the conventional pathology to a more advanced level. Digital pathology evolution contributed to faster and accurate detection and diagnosis of chronic diseases. Currently, market players adopting collaborations, product develepments and launches as key strategies. For instance, In 2016 Visiopharm, partenerd with Inter Instrument A and LRI Imaging, to deploy digital pathology systems in Scandinavia.

Some of the major players in global digital pathology are Perkin Elmer, Inc. (U.S.), Olympus Corporation (Japan), AstraZeneca plc (Definiens AG) (U.K.), Sectra AB (Sweeden), GE Healthcare (U.K.), Inspirata Co. (U.S.), The Danaher Corporation (U.S.), Koninklijke Philips N.V (Netherlands), F. Hoffmann-La Roche AG (Ventana Medical Systems) (Switzerland), Digipath Co. (U.S.), Carl Zeiss AG (Germany), 3D-Histech Ltd. (Hungary), Yokogawa Electronic Corporation (Japan), Quorum Technologies Inc. (Canada) and Hamamatsu Photonics K.K. (Japan) to name a few.

To Enquire About This Comprehensive Report@ https://www.alexareports.com/send-an-enquiry/170623

In March 2018, Danaher Corporation partened with Leeds Hospital to improve productivity and workflow

In June 2016, Royal Philips, acquired PathXL, a pathology, image-based analysis firm to develop integrated tools targeting applications in computational biology, education, workflow solutions, and image analytics

Details of the market study:

Historical Data: 2014 & 2017

Base Year: 2018

Forecasts: 2019-2025

CAGR: 2019-2025

Market trend analysis in terms of drivers, restraints and opportunities

Industry analysis using Porter’s, PESTEL and SWOT

Market players analysis in terms of company’s overview, financial performance, product/service benchmarking and strategic initiatives taken up by them

#Digital Pathology Market

0 notes

cmfelatestarticle · 5 years

Text

Digital Pathology Market is predicted to reach USD 19,456.80 million by 2030

The Global Digital Pathology Market held USD 3,524.68 million in 2018 and is predicted to reach USD 19,456.80 million by 2030 with a CAGR of 15.3% from 2019-2030

Digital pathology is also known as digital imaging, virtual slides, or virtual microscopy. It is a dynamic and image-based environment that allows procurement, administration, and interpretation of pathological information to computer screen. It enables the pathologist to observe the slide under a microscope and have digitalized image of it by using image analysis software.

Read Report Overview @

https://www.nextmsc.com/report/digital-pathology-market

The adoption of the digital pathology has increased in numerous applications that includes diagnosis of the diseases, drug discovery, and research. In addition, rising occurrence of chronic conditions has increased the demand for the digital pathology, thereby impacting the digital pathology market share in future. Also, digital pathology provides live and high resolution images that helps the pathologist to provide better diagnosis.

The digital pathology market size is expected to grow at a substantial rate by 2030. The factors including implementing faster diagnostic tools for chronic diseases, increasing adoption of digital pathology to enhance lab efficiency, and growing trend of digitalization in medical sector has majorly driven the digital pathology market. Furthermore, use of digital pathology in disease diagnosis, increasing government’s initiatives, and ease of consultation has led to rise in the demand of digital pathology. However, high cost and lack in reimbursement may limit the growth the digital pathology market. The increasing potential of digital pathology, introduction of affordable scanners for private pathology practices, and personalized medicine will create new opportunities for the market growth in future.

The digital pathology market is segmented on the basis of product, type, end user, application, and geography. On the basis of product, the market is segmented into scanner, software, storage systems, and communication system. On the basis of type, the market covers human and veterinary. On the basis of end user, the digital pathology market is classified into pharmaceutical & biotechnology companies, hospital & reference laboratories, and academic & research institutes. On the basis of application, the market is divided into teleconsultation, disease diagnosis, and drug discovery. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and LAMEA.

North America is anticipated hold the highest market share during the forecast period. This is attributable to the factors including denotes a higher adoption of the digital pathology, R&D investments, presence of major players, and high consumer awareness.

It is expected that the emerging economies, specifically in the Asia-Pacific region would witness increasing market size owing to improvement in healthcare facility, proliferation of advanced imaging modalities in emerging economies, and untapped opportunities.

Request to view Sample Report:

https://www.nextmsc.com/Digital-Pathology-Market/request-sample

Comprehensive competitive analysis and profiles of the major market players such as Nikon Corporation, PerkinElmer, Inc., Indica Labs, Inc., Koninklijke Philips N.V., Pixcelldata Ltd., Glencoe Software, Inc., Hamamatsu Photonics K.K., Visiopharm A/S, Danaher Corporation, Digipath Inc., and among others are provided in the digital pathology market report.

#Digital Pathology Market

0 notes